References
- GillSRMetagenomic analysis of the human distal gut microbiomeScience2006312 1355 135910.1126/science.11242343027896
- RoundJLMazmanianSKThe gut microbiome shapes intestinal immune responses during health and diseaseNat. Rev. Immunol.2009931332310.1038/nri25154095778
- DragicTLitwinVAllawayGPHIV-1 entry into CD4 plus cells is mediated by the chemokine receptor CC-CKR-5Nature199638166710.1038/381667a0
- SandlerNGDouekDCMicrobial translocation in HIV infection: causes, consequences and treatment opportunitiesNat. Rev. Microbiol.20121065566610.1038/nrmicro2848
- BrenchleyJMMicrobial translocation is a cause of systemic immune activation in chronic HIV infectionNat. Med.2006121365137110.1038/nm1511
- ZevinASMcKinnonLBurgenerAKlattNRMicrobial translocation and microbiome dysbiosis in HIV-associated immune activationCurr Opin HIV AIDS20161118219010.1097/COH.00000000000002344752849
- SunYFecal bacterial microbiome diversity in chronic HIV-infected patients in ChinaEmerg. Microbes Infect.2016510.1038/emi.2016.254855070
- NowakPGut microbiota diversity predicts immune status in HIV-1 infectionAIDS2015292409241810.1097/QAD.0000000000000869
- ChenJAnti-retroviral therapy decreases but does not normalize indoleamine 2,3-dioxygenase activity in hiv-infected patientsPlos ONE20149e10044610.1371/journal.pone.01004464077698
- PaiardiniMMuller-TrutwinMHIV-associated chronic immune activationImmunol. Rev.20132547810110.1111/imr.120793729961
- NixLMTienPCMetabolic syndrome, diabetes, and cardiovascular risk in HIVCurr. HIV/AIDS Rep.20141127127810.1007/s11904-014-0219-74138538
- Aron-WisnewskyJClementKThe gut microbiome, diet, and links to cardiometabolic and chronic disordersNat. Rev. Nephrol.20161216918110.1038/nrneph.2015.191
- WuGDLinking long-term dietary patterns with gut microbial enterotypesScience201133410510810.1126/science.12083443368382
- Noguera-JulianMGut microbiota linked to sexual preference and HIV infectionEBioMedicine2016513514610.1016/j.ebiom.2016.01.0324816837
- LiSXComplexities of gut microbiome dysbiosis in the context of HIV infection and antiretroviral therapyClin. Pharmacol. Ther.20169960061110.1002/cpt.3634927263
- DillonSMFrankDNWilsonCCThe gut microbiome and HIV-1 pathogenesis: a two way streetAIDS2016302737275110.1097/QAD.00000000000012895101180
- TincatiCDouekDCMarchettiGGut barrier structure, mucosal immunity and intestinal microbiota in the pathogenesis and treatment of HIV infectionAIDS Res Ther.20161310.1186/s12981-016-0103-14828806
- DubourgGSurenaudMLévyYHüeSRaoultDMicrobiome of HIV-infected peopleMicrob. Pathog.2017106859310.1016/j.micpath.2016.05.015
- DillonSAn altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemiaMucosal Immunol.2014798310.1038/mi.2013.1164062575
- McHardyIHHIV infection is associated with compositional and functional shifts in the rectal mucosal microbiotaMicrobiome2013110.1186/2049-2618-1-263971626
- MutluEAA compositional look at the human gastrointestinal microbiome and immune activation parameters in HIV infected subjectsplos Pathog.201410e100382910.1371/journal.ppat.10038293930561
- Vujkovic-CvijinIDysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolismSci. Transl. Med.20135193ra91ra9110.1126/scitranslmed.30064384094294
- LozuponeCAAlterations in the gut microbiota associated with HIV-1 infectionCell Host Microbe20131432933910.1016/j.chom.2013.08.006
- DubourgGImpact of HIV on the human gut microbiota: challenges and perspectivesHuman Micro. J.201623910.1016/j.humic.2016.10.001
- BäckhedFProgramming of host metabolism by the gut microbiotaAnn. Nutr. Metab.201158Suppl. 2445210.1159/000328042
- ScherJUDecreased bacterial diversity characterizes an altered gut microbiota in psoriatic arthritis and resembles dysbiosis of inflammatory bowel diseaseArthritis Rheumatol. (Hoboken, NJ)20156712813910.1002/art.38892
- JenabianMAImmunosuppressive tryptophan catabolism and gut mucosal dysfunction following early HIV infectionJ. Infect. Dis.201521235536610.1093/infdis/jiv037
- SherryBTOPResolution of the two components of macrophage inflammatory protein 1, and cloning and characterization of one of those components, macrophage inflammatory protein 1 betaJ. Exp. Med.19881682251225910.1084/jem.168.6.2251
- MantovaniAGrayPAVan DammeJSozzaniSMacrophage-derived chemokine (MDC)J. Leukoc. Biol.200068400404
- GaidtMMHornungVAlternative inflammasome activation enables IL-1beta release from living cellsCurr. Opin. Immunol.20174471310.1016/j.coi.2016.10.007
- ZittermannSIIssekutzACBasic fibroblast growth factor (bFGF, FGF-2) potentiates leukocyte recruitment to inflammation by enhancing endothelial adhesion molecule expressionAm. J. Pathol.200616883584610.2353/ajpath.2006.0504791606526
- KaszaAIL-1 and EGF regulate expression of genes important in inflammation and cancerCytokine201362223310.1016/j.cyto.2013.02.007
- AlamRChemokines in allergic inflammationJ. Allergy Clin. Immunol.19979927327710.1016/S0091-6749(97)70042-3
- HamiltonJAColony-stimulating factors in inflammation and autoimmunityNat. Rev. Immunol.2008853354510.1038/nri2356
- ShilaihMAntibacterial effects of antiretrovirals, potential implications for microbiome studies in HIVAntivir. Ther.201723919410.3851/IMP3173
- AhmadACombination antiretroviral therapy and indoleamine 2,3-dioxygenase in HIV infections: challenges and new opportunitiesAIDS2016301839184110.1097/QAD.0000000000001168
- Villanueva-MillanMJPerez-MatutePRecio-FernandezELezana RosalesJMOteoJADifferential effects of antiretrovirals on microbial translocation and gut microbiota composition of HIV-infected patientsJ. Int AIDS Soc.20172011310.7448/IAS.20.1.21526
- TylerADSmithMISilverbergMSAnalyzing the human microbiome: a “how to” guide for physiciansAm. J. Gastroenterol.201410998399310.1038/ajg.2014.73